drugset / Trial / NCT05416515
A Study of Fisetin to Treat Carpal Tunnel Syndrome
NaSingle-groupOpen-labelTreatment
Summary
This research study is being conducted to investigate the safety and effectiveness of the drug Fisetin for mild or moderate carpal tunnel syndrome (CTS).
Timeline
- Start
- 2022-10-09
- Primary completion
- 2024-12-31
- Completion
- 2025-01-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fisetin | Small molecule | 100 mg | Oral |